There are 2137 resources available
1667TiP - A phase II, single arm study of avelumab in combination with axitinib in patients with unresectable/metastatic gastrointestinal stromal tumor after failure of standard therapy - AXAGIST
Presenter: Katarzyna Kozak
Session: E-Poster Display
Resources:
Abstract
1668TiP - A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082)
Presenter: Nathalie Gaspar
Session: E-Poster Display
Resources:
Abstract
1669TiP - A non-randomized, open-label phase II trial evaluating efficacy and feasibility of combined treatment with trabectedin and nivolumab in patients with metastatic or inoperable soft tissue sarcomas (STS) after failure of an anthracycline-containing regimen
Presenter: Daniel Müller
Session: E-Poster Display
Resources:
Abstract
1710P - International multicentric evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits (TV) during the COVID-19 outbreak
Presenter: Alexandra Bizot
Session: E-Poster Display
Resources:
Abstract
1784P - Activity of lurbinectedin in second-line SCLC patients candidates for platinum re-challenge
Presenter: Vivek Subbiah
Session: E-Poster Display
Resources:
Abstract
1785P - Phase Ib expansion study of adavosertib plus olaparib in patients with extensive-stage or relapsed small cell lung cancer
Presenter: Bob Li
Session: E-Poster Display
Resources:
Abstract
1786P - Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study)
Presenter: Enric Carcereny Costa
Session: E-Poster Display
Resources:
Abstract
1787P - Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202)
Presenter: Ying Liu
Session: E-Poster Display
Resources:
Abstract
1789P - Fewer liver and lymph node metastases may contribute to survival benefits for patients with c-SCLC compared with SCLC
Presenter: Haiyong Wang
Session: E-Poster Display
Resources:
Abstract
1788P - Persistent sex-differences in lung cancer mortality between 2001 and 2017 in the US and EU
Presenter: Chinmay Jani
Session: E-Poster Display
Resources:
Abstract